Zinc Finger Protein Targeting

Zinc finger protein targeting employs modified DNA-binding proteins creating artificial transcription factors. Engineered zinc fingers direct transcriptional regulation. Gene therapy applications employ targeting precision. Cancer cell selectivity from targeting specificity enhances efficacy. Off-target engagement produces unintended effects.

Regulatory submissions justify targeting rationale. Clinical translation requires safety validation. Biomarker assessment confirms target engagement. Post-approval monitoring identifies off-target effects. Emerging technologies improve specificity.